Literature DB >> 31656780

Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference.

Manuel Tufoni1, Giacomo Zaccherini1, Paolo Caraceni1.   

Abstract

Entities:  

Year:  2019        PMID： 31656780      PMCID： PMC6789376          DOI： 10.21037/atm.2019.07.16

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.

Authors:  Marco Di Pascoli; Silvano Fasolato; Salvatore Piano; Massimo Bolognesi; Paolo Angeli
Journal:  Liver Int       Date:  2018-10-08       Impact factor: 5.828

2.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2018-04-10       Impact factor: 25.083

3.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Authors:  Javier Fernández; Joan Clària; Alex Amorós; Ferrán Aguilar; Miriam Castro; Mireia Casulleras; Juan Acevedo; Marta Duran-Güell; Laura Nuñez; Montserrat Costa; Mireia Torres; Raquel Horrillo; Luis Ruiz-Del-Árbol; Cándido Villanueva; Verónica Prado; Mireya Arteaga; Jonel Trebicka; Paolo Angeli; Manuela Merli; Carlo Alessandria; Niels Kristian Aagaard; German Soriano; François Durand; Alexander Gerbes; Thierry Gustot; Tania M Welzel; Francesco Salerno; Rafael Bañares; Victor Vargas; Agustin Albillos; Aníbal Silva; Manuel Morales-Ruiz; Juan Carlos García-Pagán; Marco Pavesi; Rajiv Jalan; Mauro Bernardi; Richard Moreau; Antonio Páez; Vicente Arroyo
Journal:  Gastroenterology       Date:  2019-03-22       Impact factor: 22.682

4.  Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.

Authors:  Thierry Thévenot; Christophe Bureau; Frédéric Oberti; Rodolphe Anty; Alexandre Louvet; Aurélie Plessier; Marika Rudler; Alexandra Heurgué-Berlot; Isabelle Rosa; Nathalie Talbodec; Thong Dao; Violaine Ozenne; Nicolas Carbonell; Xavier Causse; Odile Goria; Anne Minello; Victor De Ledinghen; Roland Amathieu; Hélène Barraud; Eric Nguyen-Khac; Claire Becker; Thierry Paupard; Danielle Botta-Fridlung; Naceur Abdelli; François Guillemot; Elisabeth Monnet; Vincent Di Martino
Journal:  J Hepatol       Date:  2014-11-21       Impact factor: 25.083

Review 5.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Authors:  Mauro Bernardi; Richard Moreau; Paolo Angeli; Bernd Schnabl; Vicente Arroyo
Journal:  J Hepatol       Date:  2015-07-17       Impact factor: 25.083

6.  A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.

Authors:  Javier Fernández; Joan Monteagudo; Xavier Bargallo; Wladimiro Jiménez; Jaume Bosch; Vicente Arroyo; Miguel Navasa
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 7.  Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.

Authors:  Rita Garcia-Martinez; Paolo Caraceni; Mauro Bernardi; Pere Gines; Vicente Arroyo; Rajiv Jalan
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

8.  Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms.

Authors:  Alessia Bortoluzzi; Giulio Ceolotto; Elisabetta Gola; Antonietta Sticca; Sergio Bova; Filippo Morando; Salvatore Piano; Silvano Fasolato; Silvia Rosi; Angelo Gatta; Paolo Angeli
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

9.  Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial.

Authors:  Roberto-Giulio Romanelli; Giorgio La Villa; Giuseppe Barletta; Francesco Vizzutti; Fabio Lanini; Umberto Arena; Vieri Boddi; Roberto Tarquini; Pietro Pantaleo; Paolo Gentilini; Giacomo Laffi
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

10.  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Authors:  Paolo Caraceni; Oliviero Riggio; Paolo Angeli; Carlo Alessandria; Sergio Neri; Francesco G Foschi; Fabio Levantesi; Aldo Airoldi; Sergio Boccia; Gianluca Svegliati-Baroni; Stefano Fagiuoli; Roberto G Romanelli; Raffaele Cozzolongo; Vito Di Marco; Vincenzo Sangiovanni; Filomena Morisco; Pierluigi Toniutto; Annalisa Tortora; Rosanna De Marco; Mario Angelico; Irene Cacciola; Gianfranco Elia; Alessandro Federico; Sara Massironi; Riccardo Guarisco; Alessandra Galioto; Giorgio Ballardini; Maria Rendina; Silvia Nardelli; Salvatore Piano; Chiara Elia; Loredana Prestianni; Federica Mirici Cappa; Lucia Cesarini; Loredana Simone; Chiara Pasquale; Marta Cavallin; Alida Andrealli; Federica Fidone; Matteo Ruggeri; Andrea Roncadori; Maurizio Baldassarre; Manuel Tufoni; Giacomo Zaccherini; Mauro Bernardi
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321
View more
  2 in total

Review 1.  Albumin: Indications in chronic liver disease.

Authors:  Manuel Tufoni; Giacomo Zaccherini; Paolo Caraceni; Mauro Bernardi
Journal:  United European Gastroenterol J       Date:  2020-02-26       Impact factor: 4.623

2.  Evaluation of the Effect of Selected Brominated Flame Retardants on Human Serum Albumin and Human Erythrocyte Membrane Proteins.

Authors:  Monika Jarosiewicz; Katarzyna Miłowska; Anita Krokosz; Bożena Bukowska
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.